Use of 10-hydroxy-10,11-dihydrocarbamazepin e derivatives for the treatment of affective disorders

Details for Australian Patent Application No. 2008201166 (hide)

Owner Novartis AG

Inventors Zechner, Stefanie; Martenyi, Ferenc; Schmutz, Markus

Agent Davies Collison Cave

Pub. Number AU-A-2008201166

Parent 2004226827

Filing date 12 March 2008

Wipo publication date 3 April 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 April 2008 Application Open to Public Inspection

  Published as AU-A-2008201166

3 April 2008 Complete Application Filed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201167-Gaming machine capable of setting betnumber

2008201165-Facial wetting apparatus